Biogen (BIIB), Abbott (ABT) Report DAC HYP Met Primary Endpoint in SELECT Trial
Go back to Biogen (BIIB), Abbott (ABT) Report DAC HYP Met Primary Endpoint in SELECT Trial| Abbott Laboratories (NYSE: ABT) | Delayed: 115.61 +1.47 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $114.14 | 52 Week High | $46.38 | |||
| Open | $114.02 | 52 Week Low | $36.00 | |||
| Day High | $115.76 | P/E | 77.07 | |||
| Day Low | $113.45 | EPS | $1.50 | |||
| Volume | 2,104,327 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 218.27 +3.92 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $218.85 | P/E | 27.95 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 150,754 | |||||
